Document is current
Any future updates will be listed below
-
Authors
Svennerholm, Kristina
Park, Kyong-Su
Wikström, Johannes
Lässer, Cecilia
Crescitelli, Rossella
Shelke, Ganesh V.
Jang, Su Chul
Suzuki, Shintaro
Bandeira, Elga
Olofsson, Charlotta S.
Lötvall, Jan
- License Information
-
More Information
Article History
Received: 4 September 2017
Accepted: 10 November 2017
First Online: 12 December 2017
Competing Interests
: Jan Lötvall has filed multiple patents for the utilization of exosomes and exosome-like nanovesicels for therapeutic purposes. Kyong-Su Park has filed several patents for using OMVs as sepsis model, as well investigating target molecules. Jan Lötvall and Su Chul Jang are currently employed by Codiak BioSciences, Cambridge, MA, with the goal to develop exosomes as therapeutics. The other authors have no disclosures related to this work.
